Stock Research: Alkem Laboratories

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Alkem Laboratories

NSI:ALKEM INE540L01014
55
  • Value
    37
  • Growth
    49
  • Safety
    Safety
    63
  • Combined
    58
  • Sentiment
    55
  • 360° View
    360° View
    55
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Alkem Laboratories Ltd. is an India-based pharmaceutical company focused on developing, manufacturing, and selling pharmaceutical products. The company operates in pharmaceuticals, producing branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, with offerings in various medical fields including anti-infectives, cardiology, oncology, and more. It markets products in India and over 40 international markets, with the United States as a key focus. In the last fiscal year, the company had a market cap of $6958 millions, profits of $960 millions, and revenue of $1517 millions.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
37 61 51 71
Growth
49 25 97 37
Safety
Safety
63 46 42 57
Sentiment
55 27 80 26
360° View
360° View
55 22 88 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
33 15 25 62
Opinions Change
75 31 50 13
Pro Holdings
n/a 42 83 20
Market Pulse
79 54 83 67
Sentiment
55 27 80 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
37 61 51 71
Growth
49 25 97 37
Safety Safety
63 46 42 57
Combined
58 28 85 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
30 48 50 59
Price vs. Earnings (P/E)
32 58 38 64
Price vs. Book (P/B)
22 45 44 54
Dividend Yield
63 56 47 62
Value
37 61 51 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
52 48 44 39
Profit Growth
63 47 86 34
Capital Growth
1 16 79 73
Stock Returns
83 35 91 47
Growth
49 25 97 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
65 44 48 44
Refinancing
54 60 62 64
Liquidity
66 47 37 57
Safety Safety
63 46 42 57

Similar Stocks

Discover high‑ranked alternatives to Alkem Laboratories and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

Only the professional market sentiment is positive. The stock is expensive, has low growth, and low financial safety. This is a weak investment proposition. Only a small, highly-speculative investment may be justified by investors who strongly believe the positive sentiment points to an positive future.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: